HealthQuad has raised $162 million (Rs 1,215 crore) in the final close of its second fund. The firm, which counts Medikabazaar, Ekincare, Healthifyme and Qure.ai in its portfolio of invested companies, has got global pharma maker MSD (Merck & Co, Inc.) as its anchor investor for the new fund.
Financial investors and strategic institutions in pharma and healthcare, development financial institutions (DFI), funds of funds, and large European conglomerates have backed the fund. The investor base includes Ackermans & van Haaren (AvH), Teachers Insurance and Annuity Association of America (TIAA), Quilvest, HCL Corporation, and development financial institutions such as CDC, Swedfund and SIDBI.
“We expect to back a total of 10-15 companies through the new fund. In 2022, we will be investing anywhere between $100 and $140 million,” Charles-Antoine Janssen, cofounder and chief investment officer, HealthQuad said.
Healthcare venture capitalist firm Healthquad raised $162 million in funding led by Merck & Co, inc.
